260 related articles for article (PubMed ID: 19025119)
21. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
[TBL] [Abstract][Full Text] [Related]
22. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.
Jokiranta TS; Jaakola VP; Lehtinen MJ; Pärepalo M; Meri S; Goldman A
EMBO J; 2006 Apr; 25(8):1784-94. PubMed ID: 16601698
[TBL] [Abstract][Full Text] [Related]
23. The human complement factor H: functional roles, genetic variations and disease associations.
Rodríguez de Córdoba S; Esparza-Gordillo J; Goicoechea de Jorge E; Lopez-Trascasa M; Sánchez-Corral P
Mol Immunol; 2004 Jun; 41(4):355-67. PubMed ID: 15163532
[TBL] [Abstract][Full Text] [Related]
24. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
Józsi M; Strobel S; Dahse HM; Liu WS; Hoyer PF; Oppermann M; Skerka C; Zipfel PF
Blood; 2007 Sep; 110(5):1516-8. PubMed ID: 17495132
[TBL] [Abstract][Full Text] [Related]
25. Complement factor H and hemolytic uremic syndrome.
Zipfel PF; Skerka C; Caprioli J; Manuelian T; Neumann HH; Noris M; Remuzzi G
Int Immunopharmacol; 2001 Mar; 1(3):461-8. PubMed ID: 11367530
[TBL] [Abstract][Full Text] [Related]
26. Translational mini-review series on complement factor H: structural and functional correlations for factor H.
Schmidt CQ; Herbert AP; Hocking HG; Uhrín D; Barlow PN
Clin Exp Immunol; 2008 Jan; 151(1):14-24. PubMed ID: 18081691
[TBL] [Abstract][Full Text] [Related]
27. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
Perkins SJ; Goodship TH
J Mol Biol; 2002 Feb; 316(2):217-24. PubMed ID: 11851332
[TBL] [Abstract][Full Text] [Related]
28. The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module.
Schmidt CQ; Herbert AP; Mertens HD; Guariento M; Soares DC; Uhrin D; Rowe AJ; Svergun DI; Barlow PN
J Mol Biol; 2010 Jan; 395(1):105-22. PubMed ID: 19835885
[TBL] [Abstract][Full Text] [Related]
29. Complement regulators and inhibitory proteins.
Zipfel PF; Skerka C
Nat Rev Immunol; 2009 Oct; 9(10):729-40. PubMed ID: 19730437
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.
Pickering MC; de Jorge EG; Martinez-Barricarte R; Recalde S; Garcia-Layana A; Rose KL; Moss J; Walport MJ; Cook HT; de Córdoba SR; Botto M
J Exp Med; 2007 Jun; 204(6):1249-56. PubMed ID: 17517971
[TBL] [Abstract][Full Text] [Related]
31. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
Montes T; Goicoechea de Jorge E; Ramos R; Gomà M; Pujol O; Sánchez-Corral P; Rodríguez de Córdoba S
Mol Immunol; 2008 May; 45(10):2897-904. PubMed ID: 18336910
[TBL] [Abstract][Full Text] [Related]
32. Complement factor H: physiology and pathophysiology.
Zipfel PF
Semin Thromb Hemost; 2001 Jun; 27(3):191-9. PubMed ID: 11446652
[TBL] [Abstract][Full Text] [Related]
33. Factor H genotype-phenotype correlations: lessons from aHUS, MPGN II, and AMD.
Goodship TH
Kidney Int; 2006 Jul; 70(1):12-3. PubMed ID: 16810287
[TBL] [Abstract][Full Text] [Related]
34. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates.
Schneider MC; Prosser BE; Caesar JJ; Kugelberg E; Li S; Zhang Q; Quoraishi S; Lovett JE; Deane JE; Sim RB; Roversi P; Johnson S; Tang CM; Lea SM
Nature; 2009 Apr; 458(7240):890-3. PubMed ID: 19225461
[TBL] [Abstract][Full Text] [Related]
35. Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin.
Fernando AN; Furtado PB; Clark SJ; Gilbert HE; Day AJ; Sim RB; Perkins SJ
J Mol Biol; 2007 Apr; 368(2):564-81. PubMed ID: 17362990
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of phenotypes caused by variants in the CFH gene.
Boon CJ; van de Kar NC; Klevering BJ; Keunen JE; Cremers FP; Klaver CC; Hoyng CB; Daha MR; den Hollander AI
Mol Immunol; 2009 May; 46(8-9):1573-94. PubMed ID: 19297022
[TBL] [Abstract][Full Text] [Related]
37. A haplotype in CFH family genes confers high risk of rare glomerular nephropathies.
Ding Y; Zhao W; Zhang T; Qiang H; Lu J; Su X; Wen S; Xu F; Zhang M; Zhang H; Zeng C; Liu Z; Chen H
Sci Rep; 2017 Jul; 7(1):6004. PubMed ID: 28729648
[TBL] [Abstract][Full Text] [Related]
38. The simple design of complement factor H: Looks can be deceiving.
Alexander JJ; Quigg RJ
Mol Immunol; 2007 Jan; 44(1-3):123-32. PubMed ID: 16919753
[TBL] [Abstract][Full Text] [Related]
39. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
Martínez-Barricarte R; Heurich M; López-Perrote A; Tortajada A; Pinto S; López-Trascasa M; Sánchez-Corral P; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
[TBL] [Abstract][Full Text] [Related]
40. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
